In cervical cancer, TGF-β acts as a tumor suppressor in malignant transformation, but in the early stage of the disease, it promotes tumor progression by promoting metastatic properties, epithelial-mesenchymal transition, angiogenesis, and escape from immune surveillance. This evidence concerns the gene TGFB1 and cervical cancer.